Adenocarcinoma cells in Pap smears

Pathology

Volumn 41, Issue 5, 2009, Pages 411-418

  Mulvany, Nicholas J ^a   Mitchell, Gerardine ^a   Allen, David G ^b  

^a AUSTIN HOSPITAL   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

Adenocarcinoma; Gynaecological pathology; Pap smear

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA; VIRUS DNA; WT1 PROTEIN;

ADENOCARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CARCINOMA CELL; CELL SPREADING; CELL STRUCTURE; CLEAR CELL CARCINOMA; CYSTADENOMA; ENDOMETRIUM CARCINOMA; FEMALE GENITAL SYSTEM; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MEDICAL INFORMATION; METASTASIS; OVARY ADENOCARCINOMA; PAPANICOLAOU TEST; REVIEW; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE TUBE CARCINOMA; WART VIRUS;

EID: 70350635415     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903042604     Document Type: Article

References (106)

1. Sasagawa M, Nishino K, Honma S, et al. Origin of adenocarcinoma cells observed on cervical cytology. Acta Cytol 2003; 47: 410-414
2. Ayer B, Pacey F, Greenberg M. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. II Microinvasive adenocarcinoma. Acta Cytol 1998; 32: 318-324
3. Bibbo M, editor. Comprehensive Cytopathology. 2nd ed. Philadelphia: WB Saunders, 1997.
4. Maksem JA, Meirs I, Robboy SJ. A primer of endometrial cytology with histological correlation. Diagn Cytopathol 2007; 35: 817-844
5. Australian Institute of Health and Welfare (AIHW). Cervical Screening in Australia 2004-2005. Canberra: AIHW, 2007; Cancer series number 38.
6. Smith HO, Tiffany MF, Qualls CR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24 year population based study. Gynecol Oncol 2000; 78: 97-105.
7. Renshaw AA, Mody DR, Lozano RL, et al. Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions. Arch Pathol Lab Med 2004; 128: 153-157
8. Pak SC, Martens M, Beekers R, et al. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix. ANZ J Obstet Gynecol 2007; 47: 504-507
9. Ng ABP, Reagan JW, Hawkiczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol 1974; 18: 356-361
10. Geisinger KR, Stanley MW, Raab SS, Silverman JF, Abati A. Modern Cytopathology. Philadelphia: Churchill Livingstone, 2004; Chapter 9, Invasive glandular malignancies of the gynecologic tract.
11. Gu M, Shi W, Barakat RR, et al. Pap smears in women with endometrial carcinoma. Acta Cytol 2001; 45: 555-560
12. Larson DM, Johnson KK, Reyes CN, et al. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol 1994; 84: 399-403.
13. Schneider ML, Wortmann M, Weigel A. Influence of the histologic and cytologic grade and the clinical and postsurgical stage on the rate of endometrial carcinoma detection by cervical cytology. Acta Cytol 1986; 30: 616-622
14. Song YS. Significance of positive vaginal smears in extrauterine carcinomas. Am J Obstet Gynecol 1957; 73: 341-348
15. Mulvany NJ, Östor A, Nirenberg A. Non-primary adenocarcinomas of the cervix. Pathology 1996; 28: 293-297
16. Clement P. Miscellaneous primary tumors and metastatic tumors of the uterine cervix. Semin Diagn Pathol 1990; 7: 242-244
17. 16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008; 40: 335-344
18. Mazur MT, Hsueh M. Metastatic patterns of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol 1991; 48: 28-33.
19. Ng ABP. Endometrial hyperplasia and carcinoma and extrauterine cancer. In: Bibbo M, editor. Comprehensive Cytopathology. 2nd ed. Philadelphia: WB Saunders, 1997; 251-278
20. Lemoine NR, Hall PA. Epithelial tumors metastatic to the uterine cervix: A study of 33 cases and review of the literature. Cancer 1986; 57: 2002-2005
21. Mazur MT, Hsueh M, Gersell DJ. Metastases to the female genital tract: Analysis of 325 cases. Cancer 1984; 53: 1978-1984
22. Way S. Carcinoma metastatic to the cervix. Gynecol Oncol 1980; 9: 298-302.
23. Kashimura M, Kashimura Y, Matsuyama T, et al. Adenocarcinoma of the uterine cervix metastatic from primary stomach cancer. Cytologic findings in six cases. Acta Cytol 1983; 27: 54-58
24. Moore RG, Chung M, Granai CO, et al. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2003; 93: 87-91.
25. Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Adv Anat Pathol 2007; 14: 149-177
26. Green AE, Biscotti C, Michener C, et al. Isolated cervical metastasis of breast cancer: a case report and review of the literature. Gynecol Oncol 2004; 95: 267-269
27. Atobe Y, Yoshimura T, Kako H, et al. Gastric cancer diagnosed by biopsy of the uterine cervix. Gynecol Oncol 1987; 26: 135-139
28. Fanning J, Alvarez PM, Tsukada Y, et al. Cervical implantation metastasis by endometrial adenocarcinoma. Cancer 1991; 68: 1335-1339
29. Fanning J, Alvarez PM, Tsukada Y, et al. Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol Oncol 1991; 40: 46-47
30. Reisinger SA, Staros EB, Mohiuddin M. Survival and failure analysis in stage II endometrial cancer using the revised 1988 FIGO staging system. Int J Radiat Oncol Biol Phys 1991; 21: 1027-1032
31. Eltabbakh GH, Moore AD. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 1999; 74: 80-85
32. Lauchlan SC. The secondary Mullerian system revisited. Int J Gynecol Pathol 1994; 13: 73-79
33. Wright CA, Leiman G, Burgess SM. The cytomorphology of papillary serous carcinoma of the endometrium in cervical smears. Cancer Cytopathol 1999; 87: 12-18
34. Hagiwara T, Kaku T, Kobayashi H, et al. Clinico-cytological study of uterine papillary serous carcinoma. Cytopathology 2005; 16: 125-131
35. Wang PH, Yuan CC, Lai CR. Detecting abnormal cells from primary serous peritoneal carcinoma by Pap smear. Acta Cytol 1999; 43: 1200.
36. Welch JM, Ciesla MC, Selvaggi SM. Serous papillary cystadenocarcinoma of the ovary diagnosed with the ThinPrep Pap test. Acta Cytol 2000; 44: 1122.
37. Kuebler DL, Nikrui N, Bell DA. Cytologic features of endometrial papillary serous carcinoma. Acta Cytol 1989; 33: 120-126
38. Luzzatto R, Sisson G, Luzzatto L, et al. Psammoma bodies and cells from in situ fallopian tube carcinoma in endometrial smears: a case report. Acta Cytol 1996; 40: 295-298
39. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol 2000; 24: 726-732
40. Zhou C, Matisic JP, Clement PB, Hayes MM. Cytologic features of papillary serous adenocarcinoma of the uterine cervix. Cancer Cytopathol 1997; 81: 98-104.
41. Galeria-Davidson H, Fernandez A, Navarro J, et al. Mucinous metaplasia to neoplastic lesions in endometrial samples with cytohistologic correlation. Diagn Cytopathol 1989; 5: 150-153
42. Jimenez-Ayala M, Martinez-Cabruja R, Casado ML, et al. Serous surface papillary carcinoma of the ovary metastatic to a cervical polyp: a case report. Acta Cytol 1996; 40: 765-769
43. Korhonen M, Stenback F. Adenocarcinoma metastatic to the uterine cervix. Gynecol Obstet Invest 1984; 17: 57-65.
44. Malle D, Pateinakis PA, Kapraki A, et al. Cytologic diagnosis of an ovarian adenocarcinoma metastatic to the cervix in cervicovaginal smears. Acta Cytol 2001; 45: 490-492
45. Minato H, Shimizu M, Hirokawa M, et al. Adenocarcinoma in situ of the fallopian tube; a case report. Acta Cytol 1998; 42: 1455-1457
46. Safret A, Bosch B, Bannwart F, et al. Carcinoma in situ of the fallopian tube presenting as a positive Pap smear. Acta Cytol 2004; 48: 462-464
47. Hirai Y, Chen JT, Hamada T, et al. Clinical and cytologic aspects of primary fallopian tube carcinoma. A report of 10 cases. Acta Cytol 1987; 31: 834-840
48. Sedlis A. Carcinoma of fallopian tube. Surg Clin North Am 1978; 58: 121-129
49. Angeles MA, Saigo PE. Cytologic diagnosis in rectovaginal .stulae. Acta Cytol 1994; 38: 373-376
50. Gupta D, Balsara G. Extrauterine malignancies. Role of Pap smears in diagnosis and management. Acta Cytol 1999; 43: 806-813
51. Schorge JO, Hossein SM, Hynan L, Ashfaq R. ThinPrep detection of cervical and endometrial adenocarcinoma. a retrospective cohort study. Cancer 2002; 96: 338-343
52. Selvaggi SM. Background features of endometrial carcinoma on ThinPrep cytology. Diagn Cytopathol 2005; 33: 162-165
53. Johnson JE, Rahemtulla A. Endocervical glandular neoplasia and its mimics in ThinPrep tests. A descriptive study. Acta Cytol 1999; 43: 369-375
54. 16INK4a and HPV-PCR on Thin-Prep samples with histological follow-up. Diagn Cytopathol 2008; 36: 453-459
55. 16INK4a is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear. Diagn Cytopathol 2005; 32: 21-24
56. 16INK4a positivity in benign, premalignant and malignant cervical glandular lesions: A potential diagnostic problem. Virchows Arch 2004; 445: 610-615
57. 16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004; 35: 689-696
58. 16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2006; 25: 187-194
59. Cameron RI, Maxwell P, Jenkins D, McCluggage WG. Immunohistochemical staining with MIB1, bcl2, p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tuboendometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002; 41: 313-321
60. 16INK4a in liquid-based specimens (SurePathTM) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 2002; 27: 365-370
61. Andersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001; 37: 246-250
62. 16INK4a MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001; 439: 55-61.
63. Costa S. Human papillomavirus (HPV) test and Pap smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix. Gynecol Oncol 2007; 106: 170-176
64. Todo Y, Minobe S, Okamoto K, et al. Cytological features of cervical smears in serous adenocarcinoma of the endometrium. Jpn J Clin Oncol 2003; 33: 636-641
65. Wright CA, Leiman G, Burgess SM. The cytomorphology of papillary serous carcinoma of the endometrium in cervical smears. Cancer 1999; 87: 12-18
66. Park JY, Kim HS, Hong SR, Chun YK. Cytological findings of cervicovaginal smears in women with uterine papillary serous carcinoma. J Korean Med Sci 2005; 20: 93-97
67. Hagiwara T, Kaku T, Kobayashi H, et al. Clinico-cytological study of uterine papillary serous carcinoma. Cytopathology 2005; 16: 125-131
68. Iwaya H, Jobo T, Sato R, et al. Comparative analysis of endometrial cytology in endometrial and ovarian clear cell adenocarcinomas. J Jpn Soc Clin Cytol 1995; 34: 449-455
69. Parkash V, Chacho MS. Psammoma bodies in cervicovaginal smears: Incidence and significance. Diagn Cytopathol 2002; 26: 81-86
70. Kern SB. Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears. Acta Cytol 1991; 35: 81-88
71. Parkash V, Carcangiu ML. Endometrioid endometrial adenocarcinoma with psammoma bodies. Am J Surg Pathol 1997; 21: 399-406. (Pubitemid 27184772)
72. Taft PD, Robboy SJ, Herbst AL, et al. Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol 1974; 18: 279-290
73. Rau AR, et al. Metastatic lobular mammary carcinoma diagnosed in cervicovaginal smears. A case report. Diagn Cytopathol 2003; 29: 300-302
74. Yazigi R, Sandstad J, Munoz AK. Breast cancer metastasizing to the uterine cervix. Cancer 1988; 61: 2558-2560.
75. Pambuccian SE, Bachowski GJ, Twiggs LB. Signet ring cell lobular carcinoma of the breast presenting in a cervicovaginal smear. A case report. Acta Cytol 2004; 44: 824-830
76. Perisić D, Jancić S, Kalinović D, Cekerevac M. Metastasis of lobular breast carcinoma to the cervix. J Obstet Gynaecol Res 2007; 33: 578-580
77. Mallow DW, Humphrey PA, Soper JT, et al. Metastatic lobular carcinoma of the breast diagnosed in cervicovaginal samples. A case report. Acta Cytol 1997; 41: 549-555
78. Imachi M, Tsukamoto N, Amagase H, et al. Metastatic adenocarcinoma to the uterine cervix from gastric cancer. A clinicopathologic analysis of 16 cases. Cancer 1993; 71: 3472-3477
79. Matsuura Y, Saito R, Kawagoe T, et al. Cytologic analysis of primary stomach adenocarcinoma metastatic to the uterine cervix. Acta Cytol 1997; 41: 291-294
80. McGill F, Adachi A, Karimi N, et al. Abnormal cervical cytology leading to the diagnosis of gastric cancer. Gynecol Oncol 1990; 36: 101-105
81. Insabato L, Simonetti S, De Cecio R, et al. Primary signet-ring cell carcinoma of the uterine cervix with long term follow-up: case report. Eur J Gynaecol Oncol 2007; 28: 411-414
82. Suárez-Peñaranda JM, Abdulkader I, Barón-Duarte FJ, González Patiño E, Novo-Domínguez A, Varela-Durán J. Signet-ring cell carcinoma presenting in the uterine cervix; report of a primary and metastatic cases. Int J Gynecol Pathol 2007; 26: 254-258
83. Haswani P, Arseneau J, Ferenczy A. Primary signet ring cell carcinoma of the uterine cervix: a clinicopathologic study of two cases with review of the literature. Int J Gynecol Cancer 1998; 8: 374-379
84. Kupryjanczyk J, Kujawa M. Signet-ring cells in squamous cell carcinoma of the cervix and in non-neoplastic ectocervical epithelium. Int J Gynecol Cancer 1992; 2: 152-156
85. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary. A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 2006; 30: 277-299
86. Mikami Y, Kiyokawa T, Hata S, et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 2004; 17: 962-972
87. Hashi A, Yuminamochi T, Xu JX, et al. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix. Diagn Cytopathol 2008; 36: 535-544
88. Rawlings KK, Look K, Ulbright TM. Adenocarcinoma of the cervix presenting as ovarian cancer: Diagnostic considerations. Gynecol Oncol 1996; 62: 304-308
89. Kaplan EJ, Caputo TA, Shen PUF, et al. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: A report of the first case. Gynecol Oncol 1998; 70: 289-294
90. RonnettBM,YemelyanovaAV,Vang R, et al.Endocervical adenocarcinomas with ovarian metastases: Analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol 2008; 32: 1835-1853
91. Reichert RA. Synchronous and metachronous endocervical and ovarian neoplasms: a Different interpretation of HPV data. Am J Surg Pathol 2005; 29: 1686-1687
92. Giordano G, D'Adda T, Gnetti L, et al. Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women. J Obstet Gynaecol Res 2008; 34: 210-217
93. 16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group. Int J Gynecol Pathol 2008; 27: 18-23.
94. Kato N, Sasou SI, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006; 19: 83-89
95. Kato N, Toukairin M, Asanuma I, et al. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma. Diagn Cytopathol 2007; 35: 193-197
96. Wachtel MS. WT-1 and serous carcinoma. Am J Surg Pathol 2006; 30: 921.
97. Dabbs DJ. Diagnostic Immunohistochemistry. Philadelphia: Churchill Livingstone, 2002; 547.
98. Bhargava R, Beriwal S, Dabbs DJ. Mammoglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 2007; 127: 103-113
99. Kanner WA, Galgano MT, Stoler MH, et al. Distinguishing breast carcinoma from Mullerian serous carcinoma with mammoglobin and mesothelin. Int J Gynecol Pathol 2008; 27: 491-495
100. Gabriele A, Gaudiano L. Primary malignant lymphoma of the cervix. A case report. J Reprod Med 2003; 48: 899-901.
101. Sato Y, Shimamoto T, Amada S, Asada Y, Hayashi T. Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases. Int J Gynecol Pathol 2003; 22: 226-230
102. Mousavi AS. Primary malignant melanoma of the uterine cervix: case report and review of the literature. J Low Genit Tract Dis 2006; 10: 258-263
103. Hollier LM, Boswank SE, Stringer CA. Adenocarcinoma of the lung metastatic to the uterine cervix: a case report and review of the literature. Int J Gynecol Cancer 1997; 7: 490-494
104. Uzum A. Metastatic malignant melanoma of the uterine cervix. Diagn Cytopathol 2008; 36: 769-772.
105. Deshpande AH. Primary malignant melanoma of the uterine cervix: report of a case diagnosed cervical scrape cytology and review of the literature. Diagn Cytopathol 2001; 25: 108-111
106. Kim MJ, Kim NR, Cho HY, et al. Differential diagnostic features of small cell carcinoma of the uterine cervix. Diagn Cytopathol 2008; 36: 618-623